CLINICAL TRIALS PROFILE FOR MAXALT
✉ Email this page to a colleague
All Clinical Trials for MAXALT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00360282 ↗ | Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines? | Completed | Merck Sharp & Dohme Corp. | N/A | 2006-08-01 | The purpose of this study is to determine if Rizatriptan, a migraine medication, lowers motion sickness in migraine sufferers. |
NCT00360282 ↗ | Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines? | Completed | University of Pittsburgh | N/A | 2006-08-01 | The purpose of this study is to determine if Rizatriptan, a migraine medication, lowers motion sickness in migraine sufferers. |
NCT00397254 ↗ | Two Rizatriptan Prescribing Portions for Treatment of Migraine | Completed | Merck Sharp & Dohme Corp. | Phase 4 | 2006-12-01 | The primary objective of this study is to evaluate a clinical limit (CL) of rizatriptan (9 rizatriptan 10mg Orally Disintegrating Tablet (ODT) per month) versus (vs.) a formulary limit (FL) of rizatriptan (27 rizatriptan 10mg ODT per month) as measured by the number of days of migraine per month. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MAXALT
Condition Name
Clinical Trial Locations for MAXALT
Trials by Country
Clinical Trial Progress for MAXALT
Clinical Trial Phase
Clinical Trial Sponsors for MAXALT
Sponsor Name